3963 Maple Avenue
Suite 350
Dallas, TX 75219
United States
972 499 3350
https://instilbio.com
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 49
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Bronson Crouch | Chairman & CEO | 1,14M | S.O. | 1973 |
Dr. Sandeep Laumas M.D. | CFO & Chief Business Officer | 741,52k | S.O. | 1969 |
Dr. Mark E. Dudley Ph.D. | Chief Scientific Officer | S.O. | S.O. | S.O. |
Dr. Robert Hawkins MBBS, Ph.D. | Head of Research & Development | 218,72k | S.O. | S.O. |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
L’ISS Governance QualityScore de Instil Bio, Inc. en date du 1 mai 2024 est 9. Les scores principaux sont Audit : 8; Société : 8; Droits des actionnaires : 8; Compensation : 9.